Patient and provider warnings

SOLDIERS BEWARE!

Patient and provider warnings

Due to the gross negligence associated with MSG Kinamon's case, his story was highlighted on the following:

Front page of the LA Times, 27 August 2007 (http://articles.latimes.com/2007/aug/27/nation/na-patches27)

CBS Evening News, 3 October 2007 (http://www.cbsnews.com/sections/i_video/main500251.shtml?id=3249012n)

CNN's Anderson Cooper 360°, 21 November 2007 (http://transcripts.cnn.com/TRANSCRIPTS/0711/21/acd.02.html).

June 2005 Janssen Pharmaceuticals issued a "Dear Healthcare Professional" letter outlining the indications and safe use of Duragesic® Transdermal Patches. http://www.fda.gov/medwatch/SAFETY/2005/duragesic_ddl.pdf

June 2005 the FDA issued a "Public Health Advisory" on new safety warnings regarding the use of transdermal fentanyl. http://www.fda.gov/cder/drug/infopage/fentanyl/default.htm

August 2005 ISMP (Institute for Safe Medication Practices) issued a "Safety Alert" on the use of transdermal fentanyl. http://ismp.org/newsletters/acutecare/articles/20050811.asp

The Department of Defense Patient Safety Center included a brief warning in its September/October 2005 issue of Hot Topics. (not available)

Department of Defense Patient Safety Center Safety Alert 8 - MAR 2006 http://dodpatientsafety.usuhs.mil/index.php?name=Downloads&req=viewdownloaddetails&lid=27

Duragesic® Label http://www.fda.gov/cder/foi/label/2005/19813s039lbl.pdf

http://www.ismp.org/Newsletters/acutecare/articles/20070628.asp The Institute for Safe Medication Practices

http://www.ama-assn.org/amednews/2007/07/23/hlsb0723.htm American Medical News

http://www.accessdata.fda.gov/psn/transcript.cfm?show=67#3 FDA Patient Safety News

True knowledge comes only through suffering.
Elizabeth Barrett Browning